Somatostatin Analog class drugs
4 results
Octreotide acetate (octreotide acetate)
(octreotide acetate)Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Usage: Octreotide acetate injection is indicated for reducing growth hormone and IGF-1 levels in acromegaly patients not responsive to other treatments, and for managing severe diarrhea and flushing in metastatic carcinoid tumors and watery diarrhea in VIPoma-associated tumors. Limitations exist regarding tumor size reduction and clinical improvement.
Signifor (pasireotide)
(pasireotide)Recordati Rare Diseases, Inc.
Usage: SIGNIFOR is indicated for treating adult patients with Cushing's disease when pituitary surgery is not feasible or has not resulted in a cure.
Signifor lar (pasireotide)
(pasireotide)Recordati Rare Diseases, Inc.
Usage: SIGNIFOR LAR is indicated for treating acromegaly in patients unresponsive to surgery or for whom surgery is not viable. Additionally, it is used for patients with Cushing's disease when pituitary surgery is not an option or has failed to cure the condition.
Somatuline depot (lanreotide acetate)
(lanreotide acetate)Ipsen Biopharmaceuticals, Inc.
Usage: SOMATULINE DEPOT is indicated for long-term treatment of acromegaly in patients unresponsive to surgery/radiotherapy, as well as for unresectable gastroenteropancreatic neuroendocrine tumors to improve progression-free survival, and for adults with carcinoid syndrome to reduce the need for short-acting somatostatin analogs.